USANA Health Sciences (NYSE:USNA) Upgraded at StockNews.com

USANA Health Sciences (NYSE:USNA) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Saturday.

Separately, DA Davidson upgraded shares of USANA Health Sciences to a “hold” rating in a report on Friday, December 20th.

USANA Health Sciences Stock Performance

Shares of NYSE USNA opened at $35.69 on Friday. The stock’s 50-day simple moving average is $37.88 and its 200-day simple moving average is $39.89. The firm has a market capitalization of $680.25 million, a PE ratio of 12.61, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a fifty-two week low of $31.44 and a fifty-two week high of $54.81.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.07. The firm had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter in the previous year, the firm posted $0.59 EPS. On average, sell-side analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by company insiders.

Institutional Trading of USANA Health Sciences

Large investors have recently added to or reduced their stakes in the company. Safe Harbor Fiduciary LLC bought a new stake in USANA Health Sciences in the third quarter worth $30,000. KBC Group NV raised its holdings in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after acquiring an additional 519 shares in the last quarter. Centiva Capital LP bought a new position in USANA Health Sciences in the third quarter worth $213,000. BOKF NA lifted its stake in USANA Health Sciences by 99.4% during the second quarter. BOKF NA now owns 5,526 shares of the company’s stock worth $250,000 after purchasing an additional 2,755 shares during the period. Finally, Quest Partners LLC acquired a new position in USANA Health Sciences during the third quarter worth $250,000. 54.25% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.